Matthias Brunner Selected Research

Matthias Brunner Research Topics

5	Fibrosis (Cirrhosis) 01/2022 - 01/2018
3	Corneal Neovascularization 09/2018 - 07/2016
2	Rheumatoid Arthritis 11/2023 - 01/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 01/2019
1	Wounds and Injuries (Trauma) 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Hemophilia A (Haemophilia) 08/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Cicatrix (Scar) 10/2018
1	Infections 10/2018
1	Neoplasms (Cancer) 01/2018
1	Lung Injury 01/2018
1	Keratoconus 12/2017
1	Vasculitis (Vasculitides) 01/2016
1	Acute Retinal Necrosis Syndrome 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Scleritis (Episcleritis) 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011

3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2018 - 01/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	CytokinesIBA 01/2021
1	CollagenIBA 01/2021
1	emicizumabIBA 08/2020
1	IntegrinsIBA 01/2019
1	somatostatin receptor 2IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	indium-bleomycinIBA 01/2018
1	Fos-Related Antigen-2IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2016
1	AntibodiesIBA 09/2014
1	Therapeutic UsesIBA 09/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2014
1	Pemetrexed (MTA)FDA Link 12/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2011